SCHEMBL1507353

SCHEMBL1507353

CC1=C(C)C(C)(C)C([Hf]C2=C(C)C(C)=C(C)C2(C)C)=C1C

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4576851 0.97 CTSD (0.32) CTSD
Fluoride SCHEMBL7635141 0.97 CTSD (0.32) CTSD
Bromide SCHEMBL7885903 0.97 CTSD (0.32) CTSD
Hydrochloric Acid SCHEMBL708752 0.97 CTSD (0.32) CTSD
Chloromethane SCHEMBL8165897 0.95 CTSD (0.31) CTSD
SCHEMBL4868274 0.82
Hydrochloric Acid SCHEMBL9079394 0.78 CTSD (0.31) CTSD
SCHEMBL4591283 0.78
Hydrochloric Acid SCHEMBL8964580 0.75
SCHEMBL2230540 0.73 CTSD (0.43) CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12528892-B2 Alkylation of transition metal coordination catalyst complexes EXXONMOBIL CHEMICAL PATENTS INC. (US) 2026-01-20 US claimed
US-20230141606-A1 Alkylation of Transition Metal Coordination Catalyst Complexes EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-05-11 US claimed
EP-0789623-B1 A PROCESS AND A CATALYST FOR PREVENTING REACTOR FOULING EXXONMOBIL OIL CORP (US) 2003-07-09 EP claimed
EP-0843687-B1 METALLOCENE STABILIZED ALUMOXANE EXXONMOBIL CHEM PATENTS INC (US) 2002-06-12 EP claimed
EP-0879250-B1 IMPROVED SUPPORTED METALLOCENE CATALYST SYSTEMS EXXON CHEMICAL PATENTS INC (US) 2000-09-20 EP claimed
EP-0675907-B1 A PROCESS FOR FORMING A CARRIER MATERIAL MOBIL OIL CORP (US) 1999-09-22 EP claimed
EP-0283958-B1 Olefin polymer and process for production thereof IDEMITSU KOSAN CO (JP) 1996-09-11 EP claimed
US-12528892-B2 Alkylation of transition metal coordination catalyst complexes EXXONMOBIL CHEMICAL PATENTS INC. (US) 2026-01-20 US disclosed
US-20230141606-A1 Alkylation of Transition Metal Coordination Catalyst Complexes EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-05-11 US disclosed
CN-111587257-B Mixed catalyst system with four metallocenes on a single support 埃克森美孚化学专利公司 2023-02-10 CN disclosed
CN-111278872-B Polyethylene compositions and articles made therefrom 埃克森美孚化学专利公司 2022-10-28 CN disclosed
EP-3848401-A1 ISOTACTIC PROPYLENE POLYMERS ExxonMobil Chemical Patents Inc. (US) 2021-07-14 EP disclosed
EP-3301119-B1 ISOTACTIC PROPYLENE POLYMERS EXXONMOBIL CHEMICAL PATENTS INC (US) 2021-03-17 EP disclosed
EP-1463738-A1 PARTIALLY FLUORINATED NAPHTHYL-BASED BORATES Exxonmobil Chemical Patents Inc. (US) 2004-10-06 EP disclosed
EP-1461152-A1 BULKY BORATE ACTIVATORS ExxonMobil Chemical Patents Inc. (US) 2004-09-29 EP disclosed
EP-1448568-A2 DICOPS CONTAINING ACETYLENIC SUBSTITUENTS ExxonMobil Chemical Patents Inc. (US) 2004-08-25 EP disclosed
US-20040152591-A1 Polymerized metallocene catalyst composition EXXONMOBIL CHEMICAL PATENTS, INC. 2004-08-05 US disclosed
WO-2003051892-A1 PARTIALLY FLUORINATED NAPHTHYL-BASED BORATES EXXONMOBIL CHEMICAL PATENTS INC. (US) 2003-06-26 WO disclosed
WO-2003049856-A1 BULKY BORATE ACTIVATORS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2003-06-19 WO disclosed
WO-2003040070-A2 DICOPS CONTAINING ACETYLENIC SUBSTITUENTS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2003-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12528892-B2 Alkylation of transition metal coordination catalyst complexes LEF1, TAF1, FLI1 CTSD 2599/4885
US-20230141606-A1 Alkylation of Transition Metal Coordination Catalyst Complexes AS3MT, AP1M1, AP3M1 CTSD 3861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.